Vivos Inc (RDGL) stock
RDGLOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.05−0.00 (-2.51%)
Close on Oct 19, 2026Market cap $23.44MP/E –Yield –
Vivos operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Vivos's operating income for the twelve months ending Jun 30, 2026 was -$2.83M. For fiscal 2025 it was -$3.17M. The highest annual figure on record is -$672.52K in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$3.17M | – |
| FY2024 | Dec 31, 2024 | -$2.60M | – |
| FY2023 | Dec 31, 2023 | -$2.79M | – |
| FY2022 | Dec 31, 2022 | -$2.52M | – |
| FY2021 | Dec 31, 2021 | -$2.50M | – |
| FY2020 | Dec 31, 2020 | -$672.52K | – |
| FY2019 | Dec 31, 2019 | -$1.33M | – |
| FY2018 | Dec 31, 2018 | -$2.49M | – |
| FY2017 | Dec 31, 2017 | -$2.62M | – |
| FY2016 | Dec 31, 2016 | -$4.44M | – |
| FY2015 | Dec 31, 2015 | -$2.04M | – |
| FY2014 | Dec 31, 2014 | -$1.96M | – |
| FY2013 | Dec 31, 2013 | -$3.58M | – |
| FY2012 | Dec 31, 2012 | -$5.87M | – |
| FY2011 | Dec 31, 2011 | -$2.56M | – |
| FY2010 | Dec 31, 2010 | -$3.73M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$654.53K | – |
| Q1 FY2026 | Mar 31, 2026 | -$545.49K | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.10M | – |
| Q3 FY2025 | Sep 30, 2025 | -$531.02K | – |
| Q2 FY2025 | Jun 30, 2025 | -$674.77K | – |
| Q1 FY2025 | Mar 31, 2025 | -$863.53K | – |
| Q4 FY2024 | Dec 31, 2024 | -$661.80K | – |
| Q3 FY2024 | Sep 30, 2024 | -$843.15K | – |
| Q2 FY2024 | Jun 30, 2024 | -$522.31K | – |
| Q1 FY2024 | Mar 31, 2024 | -$577.13K | – |
| Q4 FY2023 | Dec 31, 2023 | -$942.79K | – |
| Q3 FY2023 | Sep 30, 2023 | -$687.63K | – |
| Q2 FY2023 | Jun 30, 2023 | -$914.41K | – |
| Q1 FY2023 | Mar 31, 2023 | -$248.32K | – |
| Q4 FY2022 | Dec 31, 2022 | -$705.65K | – |
| Q3 FY2022 | Sep 30, 2022 | -$277.07K | – |
| Q2 FY2022 | Jun 30, 2022 | -$787.54K | – |
| Q1 FY2022 | Mar 31, 2022 | -$747.49K | – |
| Q4 FY2021 | Dec 31, 2021 | -$218.44K | – |
| Q3 FY2021 | Sep 30, 2021 | -$194.58K | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.85M | – |
| Q1 FY2021 | Mar 31, 2021 | -$235.09K | – |
| Q4 FY2020 | Dec 31, 2020 | -$295.25K | – |
| Q3 FY2020 | Sep 30, 2020 | -$128.44K | – |
| Q2 FY2020 | Jun 30, 2020 | -$128.45K | – |
| Q1 FY2020 | Mar 31, 2020 | -$120.37K | – |
| Q4 FY2019 | Dec 31, 2019 | -$324.55K | – |
| Q3 FY2019 | Sep 30, 2019 | -$607.21K | – |
| Q2 FY2019 | Jun 30, 2019 | -$173.02K | – |
| Q1 FY2019 | Mar 31, 2019 | -$225.20K | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.72M | – |
| Q3 FY2018 | Sep 30, 2018 | -$136.91K | – |
| Q2 FY2018 | Jun 30, 2018 | -$341.90K | – |
| Q1 FY2018 | Mar 31, 2018 | -$286.69K | – |
| Q4 FY2017 | Dec 31, 2017 | -$671.23K | -611.1% |
| Q3 FY2017 | Sep 30, 2017 | -$961.80K | – |
| Q2 FY2017 | Jun 30, 2017 | -$619.17K | – |
| Q1 FY2017 | Mar 31, 2017 | -$364.72K | – |
| Q4 FY2016 | Dec 31, 2016 | $131.33K | – |
| Q3 FY2016 | Sep 30, 2016 | -$666.41K | – |
See a number that looks wrong?